O'Neill Gilmore Neil - Insider Non-Derivative Transactions at Editas Medicine, Inc. (EDIT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 3, 2025, O'Neill Gilmore Neil's relationship to Editas Medicine, Inc. (EDIT) is Director,Officer (CEO), and currently has 269,087 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other EDIT insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
O'Neill Gilmore Neil - Insider Non-Derivative Transactions of EDIT Common Stock
O'Neill Gilmore Neil - Insider Non-Derivative Transactions at EDIT
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Dec 4, 2025 Sell -- (Common Stock) 5603 2.15 269087
Sep 4, 2025 Sell -- (Common Stock) 5592 2.6 274690
Jun 4, 2025 Sell -- (Common Stock) 15192 1.72 280282
Mar 5, 2025 Sell -- (Common Stock) 16632 1.71 295474
Dec 4, 2024 Sell -- (Common Stock) 1618 2.08 312106
Sep 5, 2024 Sell -- (Common Stock) 1555 3.42 313724
Jun 5, 2024 Sell -- (Common Stock) 12191 5.5 315279
Mar 6, 2024 Sell -- (Common Stock) 77824 9.42 327470
Mar 3, 2024 Acquisition -- (Common Stock) 130700 0 260869
Mar 3, 2024 Acquisition -- (Common Stock) 72213 0 333082
Mar 3, 2024 Acquisition -- (Common Stock) 72212 0 405294
Jun 6, 2023 Sell -- (Common Stock) 6486 9.5 130169
Mar 3, 2023 Acquisition -- (Common Stock) 50000 0 136655